Alphamab Oncology (HKG:9966)

Revenue by Product

Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Biologics of Oncology	241.74M	Log In	Log In
Biologics of Oncology Growth	24.60%	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Year Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
China	241.74M	Log In	Log In
China Growth	24.60%	Log In	Log In